Pharmacopées, ouvrages relatifs à la pharmacie et aux médicaments

<p>CombiStats is a calculation program for the statistical analysis of data from biological dilution assays according to Ph. Eur. general chapter 5.3.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2025 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.6) and the first two supplements (11.7-11.8), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2025 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024 and<br>Supplement 11.8 published in January 2025.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.6 to Supplement 11.8.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2024 to the end of December 2025.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.6) and two non-cumulative updates (11.7 and 11.8)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>The subscription contains 3 issues in English:<br><br>Supplement 10.6 published in July 2021,<br>Supplement 10.7 published in October 2021 and<br>Supplement 10.8 published in January 2022.<br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2025 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.6) and the first two supplements (11.7-11.8), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2025 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024 and<br>Supplement 11.8 published in January 2025.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.6 to Supplement 11.8.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2024 to the end of December 2025.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.6) and two non-cumulative updates (11.7 and 11.8)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>EUROPEAN PHARMACOPOEIA 12th EDITION<br> <br>European Pharmacopoeia - Individual licence - Bilingual<br><br>As from the 12th Edition:<br>The European Pharmacopoeia is moving to an online-only format.<br>New publication cycle: each edition will comprise three issues published over a 12 month period (e.g. 12,1, 12,2, 12.3)<br>New 365-days licences (from the activation day of the licence key) with an access to all texts (current, future and archives).<br><br>This licence will grant access to all texts (past, current and future) for 365 days from the activation date.<br><br>Note: for orders placed in May and June 2025, licence keys (EPID) will be sent in July (at the latest).<br><br>Languages: bilingual (English &amp; French).<br><br>ISBN: 978-92-871-9611-8<br><br>The former three-year cycle comprising one edition and eight supplements will be replaced by an annual edition made up of three issues, numbered .1 to .3 (for example, the 12th Edition will consist of Issues 12.1, 12.2 and 12.3). Each of these issues will contain the new and revised texts adopted at one of the three European Pharmacopoeia Commission (EPC) sessions held annually. What will not change is the implementation schedule, which remains January, April and July, respectively, of the year following publication of a text. A detailed calendar presenting the EPC sessions and adoption and implementation dates will be published in due time.<br><br>All subscriptions to the 11th Edition will remain valid during the transitional period until the end of 2025. As of 1 January 2026, users will only be able to subscribe to the online version. </p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2025 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.6) and the first two supplements (11.7-11.8), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2025 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024 and<br>Supplement 11.8 published in January 2025.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.6 to Supplement 11.8.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2024 to the end of December 2025.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.6) and two non-cumulative updates (11.7 and 11.8)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2025 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.6) and the first two supplements (11.7-11.8), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2025 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024 and<br>Supplement 11.8 published in January 2025.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.6 to Supplement 11.8.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2024 to the end of December 2025.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.6) and two non-cumulative updates (11.7 and 11.8)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>La Pharmacopée Européenne (Ph. Eur.) est un ouvrage de référence unique en matière de contrôle qualité des médicaments. Les normes officielles qui y sont publiées fournissent une base scientifique au contrôle qualité durant toute la vie des médicaments.<br><br>Ces normes sont juridiquement contraignantes — ce qui est expressément stipulé dans la Convention relative à l’élaboration d’une Pharmacopée européenne et dans les législations pharmaceutiques nationales et de l’UE. Les normes qualité de la Ph. Eur. deviennent d’application obligatoire à la même date dans tous les États Parties à la convention.<br><br><br>La 10e Édition en bref<br><br> • Juridiquement contraignante dans 39 pays d’Europe et appliquée dans plus de 120 pays du monde entier<br> • Contient des nouveaux textes et des textes révisés<br> • Divulgue des informations essentielles pour les marchés européens avant toutes les autres pharmacopées<br> • La 10e Edition (Supplément 10.5 inclus) comprend 2447 monographies (y compris les formes pharmaceutiques), 378 textes généraux (y compris les monographies générales et méthodes d’analyse) et environ 2800 descriptions de réactifs.<br><br><br>Calendrier de parution<br><br>La 10e Édition de la Ph. Eur. a été publiée en juillet 2019 et sera complétée par huit suppléments périodiques (10.1 à 10.8) au cours des trois années suivantes. <br><br>Supplément 10.3 publiée en juillet 2020,<br>Supplément 10.4 publiée en octobre 2020,<br>Supplément 10.5 publiée en janvier 2021.<br><br><br>Version papier<br><br>La 10e Édition est composée de trois volumes initiaux (10.0), complétés par huit suppléments non cumulatifs (10.1 à 10.8). Par souci de commodité des utilisateurs, un accès direct aux informations complémentaires (base de données Knowledge) est inclus pour chaque monographie et chaque chapitre général (code Datamatrix). Disponible en français ou en anglais, la version papier contient une clé d’activation (code EPID) qui donne accès aux archives en ligne.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Supplement 10.3 published in July 2020,<br>Supplement 10.4 published in October 2020 and<br>Supplement 10.5 published in January 2021.<br><br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Supplement 10.3 published in July 2020,<br>Supplement 10.4 published in October 2020 and<br>Supplement 10.5 published in January 2021.<br><br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>La Pharmacopée Européenne (Ph. Eur.) est un ouvrage de référence unique en matière de contrôle qualité des médicaments. Les normes officielles qui y sont publiées fournissent une base scientifique au contrôle qualité durant toute la vie des médicaments.<br><br>Ces normes sont juridiquement contraignantes — ce qui est expressément stipulé dans la Convention relative à l’élaboration d’une Pharmacopée européenne et dans les législations pharmaceutiques nationales et de l’UE. Les normes qualité de la Ph. Eur. deviennent d’application obligatoire à la même date dans tous les États Parties à la convention.<br><br><br>La 10e Édition en bref<br><br> • Juridiquement contraignante dans 39 pays d’Europe et appliquée dans plus de 120 pays du monde entier<br> • Contient des nouveaux textes et des textes révisés<br> • Divulgue des informations essentielles pour les marchés européens avant toutes les autres pharmacopées<br> • La 10e Edition (Supplément 10.5 inclus) comprend 2447 monographies (y compris les formes pharmaceutiques), 378 textes généraux (y compris les monographies générales et méthodes d’analyse) et environ 2800 descriptions de réactifs.<br><br><br>Calendrier de parution<br><br>La 10e Édition de la Ph. Eur. a été publiée en juillet 2019 et sera complétée par huit suppléments périodiques (10.1 à 10.8) au cours des trois années suivantes. <br><br>Supplément 10.3 publiée en juillet 2020,<br>Supplément 10.4 publiée en octobre 2020,<br>Supplément 10.5 publiée en janvier 2021.<br><br><br>Version papier<br><br>La 10e Édition est composée de trois volumes initiaux (10.0), complétés par huit suppléments non cumulatifs (10.1 à 10.8). Par souci de commodité des utilisateurs, un accès direct aux informations complémentaires (base de données Knowledge) est inclus pour chaque monographie et chaque chapitre général (code Datamatrix). Disponible en français ou en anglais, la version papier contient une clé d’activation (code EPID) qui donne accès aux archives en ligne.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2025 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.6) and the first two supplements (11.7-11.8), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2025 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024 and<br>Supplement 11.8 published in January 2025.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.6 to Supplement 11.8.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2024 to the end of December 2025.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.6) and two non-cumulative updates (11.7 and 11.8)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>European Pharmacopoeia 2025 subscription:<br><br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 11th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 11th Edition of the Ph. Eur. was released in July 2024 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8). <br><br>Main volume 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024,<br>Supplement 11.8 published in January 2025.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.</p>

<p>The BP 2024 complete package<br><br> • Six-volume printed edition, including the BP (Veterinary) 2023<br> • Single-user online licence<br> • Single-user download for offline use<br><br><br>BP 2024<br>Available from 1 August 2023 | Effective from 1 January 2024 | Superseding the BP 2023.<br><br> BP 2024 supersedes the BP 2023 and becomes legally effective on 1 January 2024. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>27 new BP monographs, 17 new Ph. Eur. monographs.<br><br>93 amended BP monographs.<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 and 11.2.<br><br>Ph. Eur. supplements 11.3 to 11.5 included as in-year online and download product updates.<br><br>The BP 2024 package<br>The complete package is a great value-for-money option including:<br><br>A six-volume printed edition, including the BP (Veterinary) 2023<br><br>A single-user online licence*<br><br>A single-user download for offline use*<br><br>Other formats are available to ensure users get the best value access to the information they need.<br><br>Add the BP Archive option to the standard package and receive online access to all the BP editions from 2014 to date.<br><br>Online users can also choose to add the British Approved Names (BAN) 2023 to their package, gaining easy access to this useful reference source of medicinal substance names.</p>

<p>The BP 2025 complete package<br><br> • Six-volume printed edition, including the BP (Veterinary) 2024<br> • Single-user online licence<br> • Single-user download for offline use<br><br><br>BP 2025<br>Available from 1 August 2024 | Effective from 1 January 2025 | Superseding the BP 2025.<br><br> BP 2025 supersedes the BP 2024 and becomes legally effective on 1 January 2025. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>14 new BP monographs, 32 new Ph. Eur. monographs.<br><br>105 amended BP monographs.<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.3 and 11.5.<br><br>Ph. Eur. supplements 11.6 to 11.8 included as in-year online and download product updates.<br><br>The BP 2025 package<br>The complete package is a great value-for-money option including:<br><br>A six-volume printed edition, including the BP (Veterinary) 2025<br><br>A single-user online licence*<br><br>A single-user download for offline use*<br><br>Other formats are available to ensure users get the best value access to the information they need.<br><br>Add the BP Archive option to the standard package and receive online access to all the BP editions from 2014 to date.<br><br>Online users can also choose to add the British Approved Names (BAN) 2023 to their package, gaining easy access to this useful reference source of medicinal substance names.</p>